These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 30764856)
1. NephroCheck: should we consider urine osmolality? Noto A; Cortegiani A; David A Crit Care; 2019 Feb; 23(1):48. PubMed ID: 30764856 [No Abstract] [Full Text] [Related]
2. Back-to-back comparison of penKID with NephroCheck® to predict acute kidney injury at admission in intensive care unit: a brief report. Gayat E; Touchard C; Hollinger A; Vieillard-Baron A; Mebazaa A; Legrand M; Crit Care; 2018 Jan; 22(1):24. PubMed ID: 29378645 [No Abstract] [Full Text] [Related]
3. Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Risk Stratification of Acute Kidney Injury in Patients With Sepsis. Honore PM; Nguyen HB; Gong M; Chawla LS; Bagshaw SM; Artigas A; Shi J; Joannes-Boyau O; Vincent JL; Kellum JA; Crit Care Med; 2016 Oct; 44(10):1851-60. PubMed ID: 27355527 [TBL] [Abstract][Full Text] [Related]
4. Biomarkers. How precise is NephroCheck®? Edwards JK Nat Rev Nephrol; 2015 Mar; 11(3):127. PubMed ID: 25643663 [No Abstract] [Full Text] [Related]
9. NephroCheck data compared to serum creatinine in various clinical settings. Pajenda S; Ilhan-Mutlu A; Preusser M; Roka S; Druml W; Wagner L BMC Nephrol; 2015 Dec; 16():206. PubMed ID: 26651477 [TBL] [Abstract][Full Text] [Related]
10. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment. Vijayan A; Faubel S; Askenazi DJ; Cerda J; Fissell WH; Heung M; Humphreys BD; Koyner JL; Liu KD; Mour G; Nolin TD; Bihorac A; Am J Kidney Dis; 2016 Jul; 68(1):19-28. PubMed ID: 26948834 [TBL] [Abstract][Full Text] [Related]
12. Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults. Ostermann M; McCullough PA; Forni LG; Bagshaw SM; Joannidis M; Shi J; Kashani K; Honore PM; Chawla LS; Kellum JA; Crit Care Med; 2018 Mar; 46(3):375-383. PubMed ID: 29189343 [TBL] [Abstract][Full Text] [Related]
13. The urine biomarker panel [IGFBP7]x[TIMP-2] (NephroCheck® parameter) does not correlate with IGFBP7 and TIMP-2 gene expression in urinary sediment. Knafl D; Müller M; Pajenda S; Genc Z; Hecking M; Wagner L PLoS One; 2017; 12(11):e0188316. PubMed ID: 29145491 [TBL] [Abstract][Full Text] [Related]
15. Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients. Daubin D; Cristol JP; Dupuy AM; Kuster N; Besnard N; Platon L; Buzançais A; Brunot V; Garnier F; Jonquet O; Klouche K PLoS One; 2017; 12(1):e0169674. PubMed ID: 28085896 [TBL] [Abstract][Full Text] [Related]
16. Urinary Biomarkers: Alone Are They Enough? Molitoris BA J Am Soc Nephrol; 2015 Jul; 26(7):1485-8. PubMed ID: 25535304 [No Abstract] [Full Text] [Related]
17. Novel biomarkers to anticipate acute kidney injury. Getting ahead of the curve. Bagshaw SM Am J Respir Crit Care Med; 2014 Apr; 189(8):879-82. PubMed ID: 24735028 [No Abstract] [Full Text] [Related]
18. Urine Biomarkers of Tubular Renal Cell Damage for the Prediction of Acute Kidney Injury After Cardiac Surgery-A Pilot Study. Mayer T; Bolliger D; Scholz M; Reuthebuch O; Gregor M; Meier P; Grapow M; Seeberger MD; Fassl J J Cardiothorac Vasc Anesth; 2017 Dec; 31(6):2072-2079. PubMed ID: 28803769 [TBL] [Abstract][Full Text] [Related]
19. Routine adoption of TIMP2 and IGFBP7 biomarkers in cardiac surgery for early identification of acute kidney injury. Levante C; Ferrari F; Manenti C; Husain-Syed F; Scarpa M; Hinna Danesi T; De Cal M; Corradi V; Virzì GM; Brendolan A; Nalesso F; Bezerra P; Lopez-Giacoman S; Samoni S; Senzolo M; Giavarina D; Salvador L; Bonato R; De Rosa S; Rettore E; Ronco C Int J Artif Organs; 2017 Nov; 40(12):714-718. PubMed ID: 29148021 [TBL] [Abstract][Full Text] [Related]